ArticleCurrent microbiology2026
Green Synthesis and Bioactivity Evaluation of Silver Nanoparticles from Stevia rebaudiana and the Endophyte Aspergillus versicolor.
Article in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Novel in ovo application of green-synthesized FeScientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study demonstrates the green synthesis of silver nanoparticles (AgNPs) using Stevia rebaudiana (Bertoni) Bertoni leaf extract and endophytic fungus Aspergillus versicolor strain PSFNRO-2. The synthesized nanoparticles exhibited favorable physicochemical properties, including nanoscale dimensions and crystalline structure, as confirmed by spectroscopic and microscopic analysis. Comprehensive bioactivity evaluations revealed that the endophyte-derived AgNPs possessed superior antimicrobial, antioxidant, antidiabetic, and cytotoxic properties compared to plant extract-synthesized nanoparticles. Notably, the endophyte-mediated AgNPs demonstrated significantly enhanced antibacterial efficacy against Pseudomonas aeruginosa and exhibited strong inhibitory effects on α-amylase activity, indicating potential antidiabetic properties. Phytochemical screening identified a diverse array of bioactive compounds, including flavonoids, phenolic acids, tannins, terpenoids, and steviol glycosides, which functioned synergistically as reducing/capping agents, as well as direct antimicrobial contributors. These phytochemicals work in concert with silver ions to induce oxidative stress, disrupt microbial membranes, and inhibit the growth of pathogens through multiple mechanisms. The findings highlight endophyte-mediated green synthesis as a promising biotechnological approach for producing potent therapeutic nanoparticles. This work represents the first comprehensive evaluation of AgNPs biosynthesized using Aspergillus versicolor PSFNRO-2 from Stevia rebaudiana (Bertoni) Bertoni, demonstrating their potential as sustainable alternatives to conventional antimicrobial and pharmaceutical agents.
Indexed as
Identifiers
41524745What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.